skip to content

Roche’s Half-Year Results 2022

Roche has published it's Half-Year Results for 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 21 July 2022.

Agenda
OverviewSeverin Schwan, CEO Roche Group
Pharmaceuticals DivisionBill Anderson, CEO Roche Pharmaceuticals
Diagnostics DivisionThomas Schinecker, CEO Roche Diagnostics
Financial ResultsAlan Hippe, Chief Financial and IT Officer
Questions and answers

Webinar Replay

Investors

Past IR Events
View more Events